Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CA-SP1 cleavage site is a critical region within the HIV-1 Gag polyprotein where the viral protease cleaves the capsid protein (CA) from spacer peptide 1 (SP1). This cleavage is essential for virion maturation, leading to the formation of a functional capsid and infectious virus. It is a target for maturation inhibitor drugs like bevirimat, which aim to block this cleavage and prevent proper capsid assembly.
Inhibition of HIV-1 protease-mediated cleavage at the CA-SP1 junction, preventing proper capsid assembly and virion maturation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capsid protein (CA)-SP1 Cleavage Site (CA-SP1 Cleavage Site).